Synergy Pharmaceuticals (FRA:S90) Debt-to-Asset : 1.44 (As of Sep. 2018)

Synergy Pharmaceuticals Debt-to-Asset Chart

Synergy Pharmaceuticals Annual Data
	Trend	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Debt-to-Asset		Get a 7-Day Free Trial					-	0.93	1.31	0.25	0.70

Synergy Pharmaceuticals Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Debt-to-Asset	Get a 7-Day Free Trial															0.78	0.70	0.88	1.22	1.44

Competitive Comparison of Synergy Pharmaceuticals's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Debt-to-Asset falls into.

Synergy Pharmaceuticals Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Synergy Pharmaceuticals's Debt-to-Asset for the fiscal year that ended in Dec. 2017 is calculated as

Synergy Pharmaceuticals's Debt-to-Asset for the quarter that ended in Sep. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synergy Pharmaceuticals  (FRA:S90) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Synergy Pharmaceuticals Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Synergy Pharmaceuticals (FRA:S90) Business Description